Search alternatives:
"reduced ejection fraction" » "reduced detection fraction" (Expand Search), "reduced selection fraction" (Expand Search), "reduced ejection function" (Expand Search)
"reduced ejection fraction" » "reduced detection fraction" (Expand Search), "reduced selection fraction" (Expand Search), "reduced ejection function" (Expand Search)
-
1
Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
Published 2024-12-01Subjects: Get full text
Article -
2
Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
Published 2021-02-01Subjects: Get full text
Article -
3
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
Published 2025-04-01Subjects: Get full text
Article -
4
New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
Published 2024-03-01Subjects: “…heart failure with reduced ejection fraction…”
Get full text
Article -
5
Efficacy of vericiguat in patients with chronic heart failure and reduced ejection fraction: a prospective observational study
Published 2025-02-01Subjects: “…Heart failure with reduced ejection fraction…”
Get full text
Article -
6
PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
Published 2017-09-01Subjects: “…heart failure with reduced ejection fraction…”
Get full text
Article -
7
A meta-analysis and review on the effectiveness and safety of renal denervation in managing heart failure with reduced ejection fraction
Published 2024-12-01Subjects: Get full text
Article -
8
Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
Published 2023-02-01Subjects: “…heart failure with reduced ejection fraction…”
Get full text
Article -
9
Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
Published 2020-06-01Subjects: “…heart failure with reduced ejection fraction…”
Get full text
Article -
10
-
11
Association of visceral adiposity index (VAI) with prognosis in patients with metabolic syndrome and heart failure with reduced ejection fraction
Published 2025-03-01Subjects: “…Heart failure with reduced ejection fraction…”
Get full text
Article -
12
-
13
Incidence of Rapid Rate Non‐Sustained and Sustained Ventricular Tachycardia in Implantable Cardioverter‐Defibrillator Recipients and Its Correlation With Heart Failure Guideline‐Di...
Published 2025-08-01Subjects: “…heart failure with reduced ejection fraction…”
Get full text
Article -
14
-
15
Predictors of sustained reverse remodelling in patients with heart failure with reduced ejection fraction
Published 2025-06-01Subjects: “…heart failure with reduced ejection fraction…”
Get full text
Article -
16
Prognostic Implications of Sex in Patients With Heart Failure With Mildly Reduced Ejection Fraction: Results From a Large‐Scaled Registry
Published 2025-01-01Subjects: “…heart failure with mildly reduced ejection fraction…”
Get full text
Article -
17
Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study
Published 2025-08-01Subjects: “…Heart failure with reduced ejection fraction…”
Get full text
Article -
18
Effects of SGLT2 inhibitor dapagliflozin in patients with heart failure with reduced ejection fraction
Published 2020-09-01Subjects: Get full text
Article -
19
-
20
Utilization and dose optimization of beta-blockers in chronic heart failure therapy: a mixed-methods study
Published 2025-06-01Subjects: “…Heart failure with reduced ejection fraction…”
Get full text
Article